CLPT / ClearPoint Neuro, Inc. (CLPT) Surges 7.6%: Is This an Indication of Further Gains?

ClearPoint Neuro's progress on its four-pillar strategy continues despite a challenging operating environment, with an increasing number of partners a more_horizontal

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Alessand more_horizontal

SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform more_horizontal

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Alessa more_horizontal

ClearPoint Neuro is a growth story and should be evaluated as such. I break down some of the growth factors that I consider most important. more_horizontal

SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform more_horizontal

ClearPoint Neuro, Inc. (NASDAQ:CLPT ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Joe Burnett - CEO Danilo D'Ale more_horizontal

CLPT has been growing revenues steadily and has a large addressable market. It also has a very strong moat due to the nature of the FDA approval proce more_horizontal